Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. China
  4. Shanghai Stock Exchange
  5. Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
  6. Financials
    600196   CNE000000X38

SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD.

(600196)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization1 57 94865 086125 791119 805119 805-
Enterprise Value (EV)1 72 60477 050139 217134 257131 545137 308
P/E ratio 21,7x20,5x37,8x29,5x23,6x19,8x
Yield 1,38%1,47%0,80%0,94%1,23%1,55%
Capitalization / Revenue 2,34x2,28x4,15x3,27x2,81x2,51x
EV / Revenue 2,94x2,70x4,59x3,66x3,08x2,88x
EV / EBITDA 21,1x13,1x22,2x32,2x21,4x18,9x
Price to Book 2,13x2,14x3,74x3,31x2,98x2,69x
Nbr of stocks (in thousands) 2 563 0612 562 8992 562 8992 562 8992 562 899-
Reference price (CNY) 23,326,654,051,451,451,4
Announcement Date 03/25/201903/30/202003/29/2021---
1 CNY in Million
Previous periodNext period
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales1 24 71428 58530 30736 68742 67147 659
EBITDA1 3 4375 8746 2824 1686 1567 264
Operating profit (EBIT)1 2 0914 4944 7212 8404 1255 186
Operating Margin 8,46%15,7%15,6%7,74%9,67%10,9%
Pre-Tax Profit (EBT)1 3 5804 5264 6785 8507 3638 753
Net income1 2 7083 3223 6634 4255 5696 670
Net margin 11,0%11,6%12,1%12,1%13,1%14,0%
EPS2 1,071,301,431,742,182,60
Dividend per Share2 0,320,390,430,490,630,80
Announcement Date 03/25/201903/30/202003/29/2021---
1 CNY in Million
2 CNY
Previous periodNext period
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2021 Q1 2021 Q2 2021 Q3 2021 Q4 2022 Q1 2022 Q2
Net sales1 8 0568 89610 09610 0389 3179 641
EBITDA ------
Operating profit (EBIT)1 1 1592 1681 371718727806
Operating Margin 14,4%24,4%13,6%7,15%7,80%8,36%
Pre-Tax Profit (EBT) ------
Net income ------
Net margin ------
EPS2 0,330,640,420,340,530,61
Dividend per Share ------
Announcement Date 04/26/202108/23/202110/26/2021---
1 CNY in Million
2 CNY
Previous periodNext period
Balance Sheet Analysis
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt1 14 65711 96413 42614 45211 74011 512
Net Cash position1 ------
Leverage (Debt / EBITDA) 4,26x2,04x2,14x3,47x1,91x1,58x
Free Cash Flow1 -367-706-1 8576691 7006 999
ROE (Net Profit / Equities) 10,2%11,6%10,8%11,5%12,5%14,5%
Shareholders' equity1 26 59528 75933 79038 44744 60646 139
ROA (Net Profit / Asset) 4,09%4,53%4,58%4,47%5,77%6,71%
Assets1 66 25773 34179 90498 95196 54499 363
Book Value Per Share2 10,912,414,415,517,319,1
Cash Flow per Share2 1,151,261,011,501,832,57
Capex1 3 3173 9284 4372 3802 4592 265
Capex / Sales 13,4%13,7%14,6%6,49%5,76%4,75%
Announcement Date 03/25/201903/30/202003/29/2021---
1 CNY in Million
2 CNY
Previous periodNext period
Key data
Capitalization (CNY) 119 804 926 847
Capitalization (USD) 18 899 657 177
Net sales (CNY) 30 306 981 260
Net sales (USD) 4 786 017 867
Number of employees 32 258
Sales / Employee (CNY) 939 518
Sales / Employee (USD) 148 367
Free-Float 58,6%
Free-Float capitalization (CNY) 70 187 157 893
Free-Float capitalization (USD) 11 072 276 052
Avg. Exchange 20 sessions (CNY) 1 596 688 030
Avg. Exchange 20 sessions (USD) 252 145 780
Average Daily Capital Traded 1,33%
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA